350 related articles for article (PubMed ID: 33039631)
1. The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer.
Jiang Y; Fan L
J Ethnopharmacol; 2021 Feb; 266():113456. PubMed ID: 33039631
[TBL] [Abstract][Full Text] [Related]
2. The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer.
Xue M; Ji X; Liang H; Liu Y; Wang B; Sun L; Li W
Food Funct; 2018 Feb; 9(2):1214-1223. PubMed ID: 29384543
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism.
Jiang Y; Fan L
J Ethnopharmacol; 2020 Jul; 257():112851. PubMed ID: 32283190
[TBL] [Abstract][Full Text] [Related]
4.
Xu H; Wang S; Jiang Y; Wu J; Chen L; Ding Y; Zhou Y; Deng L; Chen X
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674937
[No Abstract] [Full Text] [Related]
5. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury.
Zou YT; Zhou J; Wu CY; Zhang W; Shen H; Xu JD; Zhang YQ; Long F; Li SL
J Ethnopharmacol; 2021 Apr; 269():113722. PubMed ID: 33352240
[TBL] [Abstract][Full Text] [Related]
7. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota disorder caused by diterpenoids extracted from Euphorbia pekinensis aggravates intestinal mucosal damage.
Wang K; Xu X; Maimaiti A; Hao M; Sang X; Shan Q; Wu X; Cao G
Pharmacol Res Perspect; 2021 Oct; 9(5):e00765. PubMed ID: 34523246
[TBL] [Abstract][Full Text] [Related]
9.
Lan K; Yang H; Zheng J; Hu H; Zhu T; Zou X; Hu B; Liu H
Food Funct; 2023 Jan; 14(2):857-873. PubMed ID: 36537246
[No Abstract] [Full Text] [Related]
10. Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis.
Ye H; Ma S; Qiu Z; Huang S; Deng G; Li Y; Xu S; Yang M; Shi H; Wu C; Li M; Zhang J; Zhang F; Qin M; Huang H; Zeng Z; Wang M; Chen Y; Lin H; Gao Z; Cai M; Song Y; Gong S; Gao L
J Ethnopharmacol; 2022 Oct; 296():115457. PubMed ID: 35753609
[TBL] [Abstract][Full Text] [Related]
11. The Regulatory Effects of Licochalcone A on the Intestinal Epithelium and Gut Microbiota in Murine Colitis.
Zhang J; Cao L; Sun Y; Qing DG; Xu XQ; Wang JC; Si JY; Li N
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299424
[TBL] [Abstract][Full Text] [Related]
12. An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota.
Sun SS; Wang K; Ma K; Bao L; Liu HW
Chin J Nat Med; 2019 Jan; 17(1):3-14. PubMed ID: 30704621
[TBL] [Abstract][Full Text] [Related]
13. Insights into the inhibition of stomach cancer MKN45 cell growth by Poria cocos ethanol-soluble extract based on MAPK/PI3K signaling pathways and components cell fishing.
Xie Z; Zeng H; He D; Luo J; Liu T; Shen B; Qin Y; Zhang S; Jin J
J Ethnopharmacol; 2024 Feb; 320():117417. PubMed ID: 37977426
[TBL] [Abstract][Full Text] [Related]
14. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
[TBL] [Abstract][Full Text] [Related]
15. Protective role of casuarinin from Melastoma malabathricum against a mouse model of 5-fluorouracil-induced intestinal mucositis: Impact on inflammation and gut microbiota dysbiosis.
Chen KJ; Huang YL; Kuo LM; Chen YT; Hung CF; Hsieh PW
Phytomedicine; 2022 Jul; 101():154092. PubMed ID: 35430483
[TBL] [Abstract][Full Text] [Related]
16. Regulation of gut microbiota and intestinal metabolites by Poria cocos oligosaccharides improves glycolipid metabolism disturbance in high-fat diet-fed mice.
Zhu L; Ye C; Hu B; Xia H; Bian Q; Liu Y; Kong M; Zhou S; Liu H
J Nutr Biochem; 2022 Sep; 107():109019. PubMed ID: 35472435
[TBL] [Abstract][Full Text] [Related]
17. Poria cocos polysaccharide improves intestinal barrier function and maintains intestinal homeostasis in mice.
Duan Y; Huang J; Sun M; Jiang Y; Wang S; Wang L; Yu N; Peng D; Wang Y; Chen W; Zhang Y
Int J Biol Macromol; 2023 Sep; 249():125953. PubMed ID: 37517750
[TBL] [Abstract][Full Text] [Related]
18. Carboxymethyl pachyman (CMP) reduces intestinal mucositis and regulates the intestinal microflora in 5-fluorouracil-treated CT26 tumour-bearing mice.
Wang C; Yang S; Gao L; Wang L; Cao L
Food Funct; 2018 May; 9(5):2695-2704. PubMed ID: 29756138
[TBL] [Abstract][Full Text] [Related]
19. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
20. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
